company background image
0GRP logo

Biotage LSE:0GRP Stock Report

Last Price

kr162.65

Market Cap

kr12.9b

7D

-3.8%

1Y

40.1%

Updated

24 Apr, 2024

Data

Company Financials +

0GRP Stock Overview

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

0GRP fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Biotage AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biotage
Historical stock prices
Current Share Pricekr162.65
52 Week Highkr186.31
52 Week Lowkr84.40
Beta0.80
1 Month Change-8.13%
3 Month Change15.35%
1 Year Change40.12%
3 Year Change-13.35%
5 Year Change26.28%
Change since IPO1,697.39%

Recent News & Updates

Recent updates

Shareholder Returns

0GRPGB Life SciencesGB Market
7D-3.8%1.9%2.3%
1Y40.1%-41.7%0.6%

Return vs Industry: 0GRP exceeded the UK Life Sciences industry which returned -41.1% over the past year.

Return vs Market: 0GRP exceeded the UK Market which returned 0.3% over the past year.

Price Volatility

Is 0GRP's price volatile compared to industry and market?
0GRP volatility
0GRP Average Weekly Movement6.6%
Life Sciences Industry Average Movement7.4%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.7%

Stable Share Price: 0GRP has not had significant price volatility in the past 3 months.

Volatility Over Time: 0GRP's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1969674Torben Jorgensenwww.biotage.com

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns.

Biotage AB (publ) Fundamentals Summary

How do Biotage's earnings and revenue compare to its market cap?
0GRP fundamental statistics
Market capkr12.86b
Earnings (TTM)kr246.00m
Revenue (TTM)kr1.86b

52.3x

P/E Ratio

6.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0GRP income statement (TTM)
Revenuekr1.86b
Cost of Revenuekr713.00m
Gross Profitkr1.15b
Other Expenseskr903.00m
Earningskr246.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)3.07
Gross Margin61.71%
Net Profit Margin13.21%
Debt/Equity Ratio4.1%

How did 0GRP perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

48%

Payout Ratio

Does 0GRP pay a reliable dividends?

See 0GRP dividend history and benchmarks
When do you need to buy 0GRP by to receive an upcoming dividend?
Biotage dividend dates
Ex Dividend DateApr 26 2024
Dividend Pay DateMay 03 2024
Days until Ex dividend1 day
Days until Dividend pay date8 days

Does 0GRP pay a reliable dividends?

See 0GRP dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.